iMeds.se

Alendronat 1a Farma Veckotablett


Package leaflet: Information for the user


Alendronat 1A FarmaVeckotablett 70 mg Film-coated tablets

Alendronic acid


Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Itisparticularlyimportanttounderstandtheinformationinsection3.HowtotakeAlendronat 1A Farma Veckotablettbeforetakingthismedicine.


What is in this leaflet

1. What Alendronat 1A Farma Veckotablett is and what it is used for

2. What you need to know before you take Alendronat 1A Farma Veckotablett

3. How to take Alendronat 1A Farma Veckotablett

4. Possible side effects

5. How to store Alendronat 1A Farma Veckotablett

6. Contents of the pack and other information


What Alendronat 1A Farma Veckotablett is and what it is used for


What is Alendronat 1A Farma Veckotablett?

Alendronat 1A Farma Veckotablettis a film-coated tablet containing the active substance alendronate sodium.

What is alendronate?

Alendronate belongs to a group of non-hormonal medicines called bisphosphonates. Alendronate prevents the loss of bone that occurs in women after they have been through the menopause, and helps to rebuild bone. It reduces the risk of spine and hip fractures.


What is Alendronat 1A FarmaVeckotablett used for?

Your doctor has prescribed Alendronat 1A Farma Veckotablett to treat your osteoporosis. Alendronat 1A Farma Veckotablett reduces the risk of spine and hip fractures.


Alendronat 1A Farma Veckotablett is a once weekly treatment.


What is osteoporosis?

Osteoporosis is a thinning and weakening of the bones. It is common in women after the menopause. At the menopause, the ovaries stop producing the female hormone, oestrogen, which helps to keep a woman’s skeleton healthy. As a result, bone loss occurs and bones become weaker. The earlier a woman reaches the menopause, the greater the risk of osteoporosis.


Early on, osteoporosis usually has no symptoms. If left untreated, however, it can result in broken bones. Although these usually hurt, breaks in the bones of the spine may go unnoticed until they cause height loss. Broken bones can happen during normal, everyday activity, such as lifting, or from minor injury that would not generally break normal bone. Broken bones usually occur at the hip, spine, or wrist and can lead not only to pain but also to considerable problems like stooped posture (‘dowager’s hump’) and loss of mobility.


How can osteoporosis be treated?

Osteoporosis can be treated and it is never too late to begin treatment. Alendronat 1A Farma Veckotablett not only prevents the loss of bone but actually helps to rebuild bone you may have lost and reduces the risk of bones breaking in the spine and hip.


As well as your treatment with Alendronat 1A Farma Veckotablett, your doctor may suggest you make changes to your lifestyle to help your condition, such as:


Stopping smoking

Smoking appears to increase the rate at which you lose bone and, therefore, may increase your risk of broken bones.


Exercise

Like muscles, bones need exercise to stay strong and healthy. Consult your doctor before you begin any exercise programme.


Eating a balanced diet

Your doctor can advise you about your diet or whether you should take any dietary supplements (especially calcium and vitamin D).


What you need to know before you take Alendronat 1A Farma Veckotablett


Do not take Alendronat 1A Farma Veckotablett


If you think any of these apply to you, do not take the tablets. Talk to your doctor first and follow the advice given.


Warnings and precautions

Talk to your doctor before taking Alendronat 1A Farma Veckotablett


You may be advised to have a dental check-up before starting treatment with Alendronat 1A Farma Veckotablett. It is important to maintain good oral hygiene when being treated with Alendronat 1A Farma Veckotablett. You should have routine dental check-ups throughout your treatment and you should contact your doctor or dentist if you experience any problems with your mouth or teeth such as loose teeth, pain or swelling.


Irritation, inflammation or ulceration of the gullet (oesophagus - the tube that connects your mouth with your stomach) often with symptoms of chest pain, heartburn, or difficulty or pain upon swallowing may occur, especially if patients do not drink a full glass of water and/or if they lie down less than 30 minutes after taking Alendronat 1A Farma Veckotablett . These side effects may worsen if patients continue to take Alendronat 1A Farma Veckotablett after developing these symptoms.


Children and adolescents

Alendronat 1A Farma Veckotablett should not be given to children and adolescents.


Other medicines and Alendronat 1A Farma Veckotablett

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.


It is likely that calcium supplements, antacids, and some oral medicines will interfere with the absorption of Alendronat 1A Farma Veckotablett if taken at the same time. Therefore, it is important that you follow the advice given in section 3. “How to take Alendronat 1A Farma Veckotablett”.


Certain medicines for rheumatism or long-term pain called NSAIDs (e.g. acetylsalicylic acid or ibuprofen) might cause digestive problems. Therefore, caution should be used when these medicines are taken at the same time as Alendronat 1A Farma Veckotablett.


Alendronat 1A FarmaVeckotablettwith food and drink

It is likely that food and beverages (including mineral water) will make Alendronat 1A Farma Veckotablettless effective if taken at the same time. Therefore, it is important that you follow the advice given in section 3. “How to takeAlendronat 1A Farma Veckotablett”.


Pregnancy and breast-feeding

Alendronat 1A Farma Veckotablett is only intended for use in postmenopausal women.

You should not take Alendronat 1A FarmaVeckotablett if you are or think you may be pregnant.


You should not take Alendronat 1A FarmaVeckotablett if you are breast-feeding.


Driving and using machines

Alendronat 1A FarmaVeckotablett may affect your ability to drive or operate machines. Patients taking Alendronat 1A Farma Veckotablett can suffer from side effects including dizziness, severe muscle joint and bone pain and eye pain or inflammation. If you are affected in this way, you should contact your doctor before driving or using machinery. Individual responses to Alendronat 1A Farma Veckotablett may vary. (see section 4).


How to take Alendronat 1A Farma Veckotablett


Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.


Take one 70 mg film-coated tablet once a week.


Follow these instructions carefully to make sure you will benefit from Alendronat 1A Farma Veckotablett

1) Choose the day of the week that best fits your schedule. Every week, take one alendronate 70 mg film-coated tablet on your chosen day.


It is very important to follow instructions 2), 3), 4) and 5) to help the Alendronat 1A Farma Veckotablett reach your stomach quickly and help reduce the chance of irritating your gullet (oesophagus - the tube that connects your mouth with your stomach).


2) After getting up for the day and before taking any food, drink, or other medicine, swallow your alendronate 70 mg Film-coated tablet with a full glass of water only (not mineral water) (not less than 200 ml or 7 fl. oz.).

- Do not take with mineral water (still or sparkling).

- Do not take with coffee or tea.

- Do not take with juice or milk.


3) Do not chew the tablet or allow it to dissolve in your mouth.


4) Do not lie down - stay fully upright (sitting, standing or walking) - for at least 30 minutes after swallowing the tablet. Do not lie down until after your first food of the day.


5) Do not take Alendronat 1A FarmaVeckotablett at bedtime or before getting up for the day.


6) If you develop difficulty or pain upon swallowing, chest pain, or new or worsening heartburn, stop takingAlendronat 1A FarmaVeckotablett and contact your doctor.


7) After swallowing your Alendronat 1A Farma Veckotablett, wait at least 30 minutes before taking your first food, drink, or other medicine of the day, including antacids, calcium supplements and vitamins. Alendronat 1A Farma Veckotablett is effective only if taken when your stomach is empty.


If you take more Alendronat 1A Farma Veckotablettthan you should

If you take too many tablets by mistake, drink a full glass of milk and contact your doctor immediately. Do not make yourself vomit, and do not lie down.


If you forget to take Alendronat 1A Farma Veckotablett

If you miss a dose, just take one tablet on the morning after you remember. Do not take two tablets on the same day.Return to taking one tablet once a week, as originally scheduled on your chosen day.


If you stop taking Alendronat 1A Farma Veckotablett

It is important that you continue taking Alendronat 1A Farma Veckotablett for as long as your doctor prescribes the medicine. Sinceitis notknownhowlongyoushouldtakeAlendronat 1A Farma Veckotablett,youshoulddiscusstheneedtostayonthis medicinewithyourdoctorperiodicallytodetermineifAlendronat 1A Farma Veckotablett isstillrightforyou.


If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


4. Possible side effects


Like all medicines, this medicine can cause side effects, although not everybody gets them.


Seeyourdoctorimmediatelyifyounoticeanyofthefollowingsideeffects,whichmaybeserious, andforwhichyoumayneedurgentmedicaltreatment:


Very common(may affect more than 1 in 10 people):

bone, muscle and/or joint pain which is sometimes severe


Common(may affect up to 1 in 10 people):

heartburn; difficulty swallowing; pain upon swallowing; ulceration of the gullet (oesophagus – the tube that connects your mouth with your stomach) which can cause chest pain, heartburn or difficulty or pain upon swallowing.


Rare(may affect up to 1 in 1,000 people):


Veryrare(mayaffectupto1in10,000people):

Talk to your doctor if you have ear pain, discharge from the ear, and/or an ear infection. These could be signs of bone damage in the ear.


Other side effects that may occur:


Common(may affect up to 1 in 10 people)


Uncommon(may affect up to 1 in 100 people)


Rare(may affect up to 1 in 1,000 people)


Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.

You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.


5. How to store Alendronat 1A Farma Veckotablett


Keep this medicine out of the sight and reach of children.


Do not use this medicine after the expiry date which is stated on the carton and the blister after EXP.

The expiry date refers to the last day of that month.


This medicinal product does not require any special storage conditions


Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.


6. Contents of the pack and other information


WhatAlendronat 1A Farma Veckotablettcontains

The active substance is alendronic acid. Each film-coated tablet contains 70 mg alendronic acid (as sodium trihydrate).


The other ingredients are:

Tablets core: Microcrystalline cellulose, Colloidal anhydrous silica, Croscarmellose sodium, Magnesium stearate.

Tablets coating:

Microcrystalline cellulose, Carrageenan, Macrogol.


What Alendronat 1A Farma Veckotablettlooks like and contents of the pack

White, round, biconvex film coated tablet, debossed with “ALN 70” on one side with a diameter of approximately 10 mm.

The product is packed in OPA-Aluminium-PVC/aluminium blister and may be supplied in the following pack sizes:


2 film-coated tablets

4 film-coated tablets

6 film-coated tablets

8 film-coated tablets

12 film-coated tablets

16 film-coated tablets

20 film-coated tablets

24 film-coated tablets

40 film-coated tablets


Not all pack sizes may be marketed.


Marketing Authorisation Holder and Manufacturer

[to be completed nationally]


This medicinal product is authorised in the Member States of the EEA under the following names:


[To be completed nationally]


This leaflet was last revised in 2016-05-26


[To be completed nationally]